Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Your Article Summary
See Latest ArticlesVanoxerine: Cellular Mechanism of a New Antiarrhythmic
Journal of Cardiovascular Electrophysiology, 10/27/09
Lacerda AE et al. – Vanoxerine is a potent blocker of cardiac hERG, Na and Ca channels; block is strongly frequency–dependent especially for Na and Ca channels; and transmural dispersion of ventricular repolarization is unaffected. The multichannel block and repolarization uniformity resemble the effects of amiodarone, the exemplar atrial fibrillation drug. Vanoxerine is a completely different chemical and has none of amiodarone's toxic effects. Vanoxerine has characteristics of a potentially effective and safe antiarrhythmic.
Related Articles
Triple-negative breast cancer—current status and future directions
Annals of Oncology, 11/16/09
Relevance Score: 45%
Use of remifentanil as a sedative agent in critically ill adult patients: a meta-analysis
Anaesthesia, 11/11/09
Relevance Score: 45%
Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond
Heart Failure Reviews, 11/03/09
Relevance Score: 45%
The Impact of Bittering Agents on Pediatric Ingestions of Antifreeze
Clinical Pediatrics, 10/26/09
Relevance Score: 45%
The role of urate and xanthine oxidase in vascular oxidative stress: future directions
Therapeutics and Clinical Risk Management, 10/07/09
Relevance Score: 45%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
The Statin Choice decision aid in primary care: A randomized trial
Patient Education and Counselling, 12/04/09
Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk
Cleveland Clinic Journal of Medicine, 12/04/09
Q: Is an ACE inhibitor plus an ARB more effective than either drug alone?
Cleveland Clinic Journal of Medicine, 12/04/09
Sponsor
Article Search
Sponsor
Sponsor